Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
The recent death of teenager Jesse Gelsinger in a drug therapy trial has drawn attention to how financial conflicts of interest may compromise patient protection. While research institutions throughout the world have instituted a variety of conflict of interest guidelines, the potential conflicts associated with investigators receiving direct payment from private companies for both the recruitment of patients and the running of clinical trials in pharmaceutical research remains a relatively unexplored area. Clinical researchers undoubtedly deserve to be reasonably compensated for their participation. But these incentive mechanisms also have the potential to create conflicts of interest--both real and perceived.
Puttagunta
P Saradhi
PS
University of Alberta, Edmonton, Alberta, Canada.
Caulfield
Timothy A
TA
Griener
Glenn
G
D002170:Canada; D002986:Clinical Trials as Topic / Q000191:economics*; D016265:Conflict of Interest / Q000191:economics*; D030881:Disclosure; D004345:Drug Industry; D028744:Ethics Committees, Research; D005249:Fees and Charges; D017408:Guidelines as Topic; D006801:Humans; D018579:Patient Selection; D010820:Physicians / Q000191:economics*; D012108:Research Personnel / Q000191:economics*; D035842:Research Subjects; D012109:Research Support as Topic